Head to head
CleanSpark vs Morgan Stanley
Side-by-side on the measures that matter, with a plain-English read. Full detail: CLSK · MS
CLSK
CleanSpark
11.52-6.27%
1-year price shape — -36% over the period
Quant Rating E · 9/100
vs
MS
Morgan Stanley
189.71-0.69%
1-year price shape — +24% over the period
Quant Rating D · 64/100
1-year performance, rebased to 100
Morgan Stanley edges it on the scoreable measures. Morgan Stanley has the highest Quant Rating (64); Morgan Stanley has done best over the past year (+24%); Morgan Stanley pays the highest dividend yield.
| CLSK | MS | |
|---|---|---|
| Snapshot | ||
| Sector | Capital Markets | -- |
| Last price | 11.52 | 189.71 |
| Change today | -6.27% | -0.69% |
| 1-year return | -35.9% | +24.4% |
| Market cap | $2.96B | $297.95B |
| 52-week range | 8.00 – 23.61 | 148.51 – 230.98 |
| Valuation | ||
| P/E (TTM) | -3.05 | 15.32 |
| P/E percentile, own 5-yr range | 60th | 46th |
| P/B | 3.89 | 2.80 |
| Dividend yield | 0.00% | 2.11% |
| Profitability & growth | ||
| EPS (TTM) | 1.12 | 10.21 |
| Net profit (TTM) | $287.64M | $16.04B |
| Revenue (TTM) | $679.25M | $73.05B |
| Revenue growth (YoY) | -30.5% | +27.4% |
| Gross margin | 28.1% | -- |
| Operating margin | -52.8% | -- |
| Net margin | -151.4% | 26.8% |
| Free cash flow (TTM) | $-1.04B | $-18.58B |
| Ownership & sentiment | ||
| Institutional ownership | 97.5% | 87.0% |
| Insider activity (12mo) | 25 buy / 25 sell | 23 buy / 27 sell |
| Short interest (% of float) | 30.6% | 0.9% |
| Analyst consensus | 100% buy (11) | 62% buy / 38% hold (13) |
| Analyst price target | $24 (+107%) | $241 (+27%) |
| StockVane view | ||
| StockVane Quant Rating | E (9) | D (64) |
| Company | ||
| Employees | 314 | 83,000 |
| Founded | 1987 | 1924 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.